Evolve Private Wealth LLC Invests $814,000 in BlackRock Capital Allocation Term Trust $BCAT

Evolve Private Wealth LLC acquired a new stake in shares of BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 51,089 shares of the company’s stock, valued at approximately $814,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Keebeck Wealth Management acquired a new stake in shares of BlackRock Capital Allocation Term Trust in the 2nd quarter worth $5,607,000. OneAscent Family Office LLC purchased a new stake in BlackRock Capital Allocation Term Trust in the second quarter valued at about $498,000. BlackRock Inc. acquired a new stake in BlackRock Capital Allocation Term Trust in the second quarter worth about $152,000. Joseph P. Lucia & Associates LLC purchased a new stake in shares of BlackRock Capital Allocation Term Trust during the second quarter worth about $534,000. Finally, Global Retirement Partners LLC purchased a new stake in shares of BlackRock Capital Allocation Term Trust during the second quarter worth about $115,000. Hedge funds and other institutional investors own 36.12% of the company’s stock.

BlackRock Capital Allocation Term Trust Stock Down 0.1%

Shares of BlackRock Capital Allocation Term Trust stock opened at $15.89 on Monday. The company has a 50 day moving average price of $15.79 and a 200 day moving average price of $15.31. BlackRock Capital Allocation Term Trust has a 52 week low of $13.73 and a 52 week high of $16.20.

BlackRock Capital Allocation Term Trust Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Tuesday, September 15th will be paid a dividend of $0.2542 per share. The ex-dividend date is Tuesday, September 15th. This represents a c) dividend on an annualized basis and a yield of 19.2%.

BlackRock Capital Allocation Term Trust Company Profile

(Free Report)

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.

See Also

Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report).

Institutional Ownership by Quarter for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.